Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Glurenorm
Synonyms :
gliquidone
Class :
Antidiabetic Agent, Sulfonylurea
Brand Name :
Glurenorm
Synonyms :
gliquidone
Class :
Antidiabetic Agent, Sulfonylurea
Dosage Forms & StrengthsÂ
Tablet Â
30 mgÂ
Take initial dose of 15 mg orally one time in a day prior to breakfast
Not determined Â
Refer to adult dosingÂ
Dipeptidyl Peptidase-IV Inhibitors: they may increase the hypoglycemic effect of sulfonylureas
Dipeptidyl Peptidase-IV Inhibitors: they may increase the hypoglycemic effect of sulfonylureas
may increase the therapeutic efficacy of each other when combined
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
it may diminish the metabolism when combined with azelastine
When halometasone is used together with gliquidone, this leads to elevated risk or seriousness of hyperglycemia
may have an increased adverse/toxic effect when combined with alcohol
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
the efficacy of gliquidone can be raised when used in combination with sulfametopyrazine
When gliquidone is used together with diazoxide, this leads to reduction in therapeutic effectiveness of gliquidone
methylprednisolone hemisuccinateÂ
When methylprednisolone hemisuccinate is aided with gliquidone, this leads to elevated hyperglycemia risk
may enhance the hypoglycemic effect of Agents with blood glucose lowering effects
may enhance the hypoglycemic effect of Agents with blood glucose lowering effects
may enhance the hypoglycemic effect of Agents with blood glucose lowering effects
may enhance the hypoglycemic effect of Agents with blood glucose lowering effects
may enhance the hypoglycemic effect of Agents with blood glucose lowering effects
may enhance the hypoglycemic effect
may enhance the hypoglycemic effect
may have an increased adverse/toxic effect when combined with alcohol
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
lansoprazole, amoxicillin, and clarithromycin
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
bismuth subcitrate, metronidazole and tetracycline
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
Actions and SpectrumÂ
The primary focus of gliquidone’s action are the pancreatic beta cells found in the pancreatic islets of Langerhans. In reaction to elevated blood sugar levels, these cells oversee generating and releasing insulin. The beta cells’ ATP-sensitive potassium (KATP) channels are the receptors to which gliquidone binds.Â
Frequency not defined Â
Skin rashes Â
Pruritus Â
Cholestatic jaundiceÂ
Exfoliative dermatitisÂ
Weight gainÂ
GI disturbancesÂ
Metallic tasteÂ
Facial flushing Â
Blood disordersÂ
PhotosensitivityÂ
HypoglycemiaÂ
Increased appetiteÂ
Black Box WarningÂ
None
Contraindication/Caution:Â
Contraindication:Â
Caution:Â
Pregnancy consideration:Â
Pregnancy category: N/AÂ
Lactation: Excretion into human milk is unknown Â
Pregnancy Categories:        Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology Â
The pancreatic beta cells’ ATP-sensitive potassium (KATP) channels are the mechanism by which gliquidone exerts its effects. Based on glucose levels, these channels oversee controlling the release of insulin. Gliquidone interacts with certain receptors on the pancreatic beta cells’ surface KATP channels.Â
PharmacodynamicsÂ
The enhanced insulin secretion caused by gliquidone leads to improved glucose control. Insulin helps to facilitate the uptake of glucose by various tissues, such as skeletal muscle and adipose tissue, thus reducing the concentration of glucose in the bloodstream. Â
PharmacokineticsÂ
Absorption  Â
gliquidone is rapidly absorbed from the gastrointestinal tract into the bloodstream. Â
DistributionÂ
gliquidone is distributed throughout the body. Â
MetabolismÂ
gliquidone undergoes metabolism in the liver through various enzymatic processes. Â
Elimination and excretionÂ
gliquidone is excreted primarily in the urine.
AdministrationÂ
gliquidone is usually taken orally and it is available in tablet and capsule form. Â
Patient information leafletÂ
Generic Name: gliquidoneÂ
Why do we use gliquidone?Â
gliquidone is used for the treatment of type 2 diabetes mellitus.  Â
gliquidone is used to achieve better blood sugar control in people with type 2 diabetes.  Â
gliquidone helps to regulate blood glucose levels and prevent hyperglycemia i.e., high blood sugar. Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
